We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-2.75%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.1B
AUM Growth
+$273M
Cap. Flow
-$650M
Cap. Flow %
-4.61%
Top 10 Hldgs %
32.88%
Holding
703
New
Increased
221
Reduced
319
Closed
43

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$41.6M
2
NVDA icon
NVIDIA
NVDA
+$36M
3
ISRG icon
Intuitive Surgical
ISRG
+$33.8M
4
AMAT icon
Applied Materials
AMAT
+$32.4M
5
XP icon
XP
XP
+$31M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$57.8M
2
JNJ icon
Johnson & Johnson
JNJ
+$54.9M
3
DHR icon
Danaher
DHR
+$41.9M
4
MSFT icon
Microsoft
MSFT
+$40.7M
5
LRCX icon
Lam Research
LRCX
+$37.4M

Sector Composition

Rank Sector Weight
1 Healthcare 26.08%
2 Technology 25.64%
3 Financials 11.81%
4 Industrials 7.9%
5 Materials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSLA icon
26
Tesla
TSLA
$1.24T
$94.5M 0.67%
377,754
+9,963
+3% +$2.56M
CSCO icon
27
Cisco
CSCO
$450B
$94.1M 0.67%
1,750,183
+112,809
+7% +$6.09M
HOLX
28
DELISTED
Hologic
HOLX
$89.7M 0.64%
1,292,732
+25,037
+2% +$1.89M
EMR icon
29
Emerson Electric
EMR
$82.9B
$86.9M 0.62%
899,362
+29,757
+3% +$2.83M
ADSK icon
30
Autodesk
ADSK
$44.3B
$81.4M 0.58%
393,434
-557
-0.1% -$117K
WM icon
31
Waste Management
WM
$95.9B
$80.8M 0.57%
530,103
-19,353
-4% -$3.13M
CRM icon
32
Salesforce
CRM
$134B
$79.2M 0.56%
390,366
-9,832
-2% -$2.12M
AVGO icon
33
Broadcom
AVGO
$1.82T
$78.5M 0.56%
945,290
-203,630
-18% -$17.7M
JNJ icon
34
Johnson & Johnson
JNJ
$635B
$75.8M 0.54%
486,908
-332,735
-41% -$54.9M
PEP icon
35
PepsiCo
PEP
$186B
$75.6M 0.54%
446,453
+124,797
+39% +$22.7M
ED icon
36
Consolidated Edison
ED
$41.6B
$75M 0.53%
876,976
+208,497
+31% +$19M
HD icon
37
Home Depot
HD
$332B
$74.9M 0.53%
247,868
+8,945
+4% +$2.88M
JPM icon
38
JPMorgan Chase
JPM
$939B
$74.4M 0.53%
512,768
-17,317
-3% -$2.6M
AMD icon
39
Advanced Micro Devices
AMD
$851B
$73.2M 0.52%
712,005
-111,503
-14% -$12.1M
ABT icon
40
Abbott
ABT
$180B
$72.2M 0.51%
745,532
-104,370
-12% -$11M
BAC icon
41
Bank of America
BAC
$435B
$71.2M 0.5%
2,599,990
-58,809
-2% -$1.74M
PTC icon
42
PTC
PTC
$13.7B
$70.8M 0.5%
500,000
+574
+0.1% +$82.1K
EQIX icon
43
Equinix
EQIX
$107B
$69.6M 0.49%
95,891
+6,887
+8% +$5.33M
CDNS icon
44
Cadence Design Systems
CDNS
$90B
$68.9M 0.49%
294,255
-6,184
-2% -$1.45M
NKE icon
45
Nike
NKE
$61.9B
$67.5M 0.48%
706,401
+80,121
+13% +$8.24M
SPGI icon
46
S&P Global
SPGI
$126B
$66.8M 0.47%
182,839
+13,183
+8% +$5.18M
ROK icon
47
Rockwell Automation
ROK
$51.4B
$64.7M 0.46%
226,349
+2,711
+1% +$838K
WCN
48
Waste Connections
WCN
$42.8B
$64.2M 0.45%
477,741
-9,838
-2% -$1.38M
MELI icon
49
Mercado Libre
MELI
$91.3B
$63.6M 0.45%
50,139
+5,012
+11% +$6.37M
BIIB icon
50
Biogen
BIIB
$29.9B
$60.1M 0.43%
233,959
+62
+0% +$16.6K

Similar funds

Candriam SCA's Q3 2023 Portfolio in Review

As of Q3 2023, Candriam SCA held 703 positions worth $14.1B, up 2% from $13.8B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Candriam SCA withdrew a net $650M in Q3 2023, closing 43 positions and reducing 319 holdings. Its most notable exit was Chinook Therapeutics, Inc. Common Stock, an estimated $31.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA added an estimated $41.6M to Amgen.

  • Candriam SCA added most to Amgen in Q3 2023, an estimated $41.6M increase.
  • Candriam SCA's biggest Q3 2023 reduction was Visa, cutting an estimated $57.8M.
  • Candriam SCA fully exited Chinook Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $31.7M.
  • Candriam SCA's ten largest holdings make up 33% of its $14.1B portfolio in Q3 2023.
  • Candriam SCA opened 0 new positions and closed 43 in Q3 2023.
  • Candriam SCA's portfolio value rose 2% quarter-over-quarter to $14.1B.

Based on Candriam SCA's 13F filing for Q3 2023, filed 13 Nov 2023.